Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors

Medicine and Dentistry

• Vasculotropin 100%
• Rapamycin 41%
• Neuroblastoma Cell 25%
• Mechanistic Target of Rapamycin 25%
• Rhabdomyosarcoma Cell 25%
• Solid Malignant Neoplasm 16%
• Oxygen 16%
• Neuroblastoma Cell Line 16%
• Phosphoinositide 3-Kinase 16%
• Hypoxia Inducible Factor 1 16%
• Rhabdomyosarcoma Cell Line 16%
• Cells 16%
• Cell Line 16%
• Phosphorylation 8%
• Signal Transduction 8%
• Cancer Cell 8%
• Stimulation 8%
• Cell Proliferation 8%
• Hypoxia 8%
• Childhood Cancer 8%
• Mitogen Activated Protein Kinase 3 8%
• Mammalian Target of Rapamycin Inhibitor 8%
• Rhabdomyosarcoma 8%
• Glycogen Synthase Kinase 3 8%
• Regulatory Mechanism 8%
• Childhood 8%
• Pediatrics 8%

Biochemistry, Genetics and Molecular Biology

• Vascular Endothelial Growth Factor 100%
• Solid 16%
• Hypoxia Inducible Factor 1 16%
• Childhood 16%
• Phosphorylation 8%
• Signal Transduction 8%
• Cancer Cell 8%
• Cell Proliferation 8%
• Contrast 8%
• Animal Models 8%
• Regulatory Mechanism 8%
• Pediatrics 8%

Neuroscience

• Cell Line 50%
• Neuroblastoma 41%
• Mammalian Target of Rapamycin 33%
• Phosphoinositide 3-Kinase 16%
• Hypoxia Inducible Factor 1 16%
• In Vivo 8%
• Cell Signaling 8%
• Phosphorylation 8%
• Cell Proliferation 8%
• Glycogen Synthase Kinase 3 8%
• Extracellular Signal-Regulated Kinases 8%
• Pediatrics 8%